Ibex Technologies【IBT】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

1.44

買値

1.25

売値

1.45

出来高

0.00 日の範囲 0.00

0.82 52 週間の範囲 1.45

時価総額

35.652M

前日終値

1.44

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

発行済株式数

24,758,000

配当利回り

PER

9.16

1 株当たり利益 (EPS)

0.16

歳入

7.49M

純利益

3.89M

セクター

In Vitro,in Vivo Diagnostics

業界

Pharmaceutical Preparations

ウェブサイト

www.ibex.ca

本社

Montreal, Quebec, Can

設立

1972

Ibex Technologies Inc is listed in the In Vitro,in Vivo Diagnostics sector of the トロントベンチャー取引所 with ticker IBT. The last closing price for Ibex Technologies was $1.44. Over the last year, Ibex Technologies shares have traded in a share price range of $ 0.82 to $ 1.45.

Ibex Technologies currently has 24,758,000 shares in issue. The market capitalisation of Ibex Technologies is $35.65 million. Ibex Technologies has a price to earnings ratio (PE ratio) of 9.16.

IBEX Completes Sale of the Company

MONTRÉAL, April 08, 2024 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) announces that it has completed the sale of the company by amalgamating with...

IBEX Shareholders Approve Sale of the Company

MONTRÉAL, Québec, April 03, 2024 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) is pleased to announce that at an annual and special meeting...

IBEX Reports Results for the Second Quarter and Six Months Ended January 31, 2024

MONTRÉAL, March 22, 2024 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the second quarter and the six...

IBEX Files Addendum to Management Proxy Circular for Sale of the Company at $1.45 Per Share

MONTRÉAL, March 14, 2024 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) announces that it has filed an addendum to its management proxy circular...

IBEX Files Management Proxy Circular for Sale of the Company at $1.45 Per Share

- Shareholders holding an aggregate of 47.15% of IBEX’s outstanding shares have entered into Support and Voting Agreements with the purchaser - IBEX Board unanimously recommends that shareholders...

IBEX Technologies Signs Definitive Agreement for Sale of the Company for $1.45 Cash Per Share

MONTREAL, Feb. 12, 2024 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) is pleased to announce that it has entered into a binding acquisition agreement...

IBEX Reports Results for the First Quarter Ended October 31, 2023

MONTRÉAL, Dec. 14, 2023 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the three months ended October 31...

IBEX Reports Results for the Year Ended July 31, 2023

MONTRÉAL, Nov. 09, 2023 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the fiscal year ended July 31, 2023...

IBEX Technologies Announces Renewal of Normal Course Issuer Bid

MONTREAL, July 17, 2023 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today announced that the TSX Venture Exchange (“TSXV”) has conditionally approved...

IBEX Reports Results for the Third Quarter and the Nine Months Ended April 30, 2023

MONTRÉAL, June 07, 2023 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the third quarter and the nine...